AmphetamineAmphetaminesCentral Nervous System StimulantsDextroamphetamineBrain ChemistryAmphetamine-Related DisordersMethamphetamineBrain InjuriesBrain NeoplasmsSubstance Abuse DetectionN-Methyl-3,4-methylenedioxyamphetamineBrain MappingDopamineBrainBehavior, AnimalStereotyped Behavior3,4-MethylenedioxyamphetamineRats, Sprague-DawleyDopamine AgentsNucleus AccumbensMotor ActivityGas Chromatography-Mass SpectrometryDopamine Uptake InhibitorsStreet DrugsBrain StemCocaineDesigner DrugsCorpus StriatumBrain EdemaAppetite DepressantsDopamine Plasma Membrane Transport ProteinsBrain IschemiaNeuronsMagnetic Resonance ImagingDose-Response Relationship, DrugHallucinogensMicrodialysisBrain AbscessEnzyme Multiplied Immunoassay TechniqueNeostriatumForensic MedicineMethylphenidateMethyltyrosinesp-ChloroamphetamineReceptors, Dopamine D2Time FactorsDopamine AgonistsCaudate NucleusDopamine AntagonistsAdrenergic Uptake InhibitorsRewardSerotoninNomifensineCerebral CortexPhenmetrazineFenfluraminePsychoses, Substance-InducedConditioning, OperantAnalysis of VariancePyrazolonesEphedrineSubstance Withdrawal SyndromeRats, WistarRats, Long-EvansHypoxia, BrainBenzphetamineBrain Damage, ChronicBlood-Brain BarrierDrug InteractionsVentral Tegmental AreaSerotonin AgentsNerve Tissue ProteinsHyperkinesisSubstance-Related DisordersBarbituratesInjections, IntraperitonealBiogenic MonoaminesPargylineRacloprideDisease Models, AnimalPrefrontal CortexSelf Administrationalpha-MethyltyrosineReceptors, Biogenic AminePhenethylaminesReceptors, DopamineHippocampusPutamenApomorphineExploratory BehaviorReserpineAdrenergic AgentsPhenylpropanolamineLocomotionStartle ReactionPsychotropic DrugsMonoamine Oxidase InhibitorsReceptors, Dopamine D1Conditioning (Psychology)Biogenic Amines